Medicare Reintroduces Mandatory Drug Pricing Models
Ophthalmologists should continue buying and billing for eye drugs the same way. If patients' out-of-pocket costs go down, the amount Medicare pays physicians will go up to match.
Member exclusive - Locked
May 14, 2025
White House Issues Executive Order on Lowering Drug Prices
The order could tie U.S. prices to the lowest price paid by a select number of developed countries.
Member exclusive - Locked
June 21, 2023
HHS and MedPAC Reports Encourage Significant Changes to Part B Drug Payment
HHS and MedPAC Reports Encourage Significant Changes to Part B Drug Payment
The Academy is monitoring congressional reaction to these reports given that the recommendations would impact ophthalmologists.
Member exclusive - Locked
January 18, 2023
CMS Announces Timeline for Negotiated Medicare Drug Pricing
The key provision from the Inflation Reduction Act is not expected to affect ophthalmic drugs in the short term.
Member exclusive - Locked
December 9, 2020
Academy Urges HHS to Halt Most Favored Nation Drug Pricing Demonstration
We’re working to make sure that a demonstration plan that becomes effective Jan. 1 won’t limit patients’ access to treatment.
June 20, 2018
Academy to Feds: Step Therapy is Risky Drug Policy for Ophthalmology
We're working to thwart proposals that could cost our patients their sight by offering other ways to lower drug costs
